KHLORIS BIOSCIENCES, INC.
Patient-derived induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM) panel for drug cardiotoxicity screening
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2017
- Latest Form D
- $5M, Dec 2018
- Total capital
- $6.7M
- Federal grants
- $1.7M
- 1 award · 2022
- Rank in peer group#11 of 32
- Private capital raised
- $5M
- 1 Form D · last Dec 2018
- 95 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 8 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery$1.7M
- Private capital raisedForm D · SEC · 1st filing$5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 32 peers
Line = medianBiotech · Instrument
- Federal grants#11 · top 34%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Lynne A. BuiResearcherExecutive Officer, DirectorLinked by $1.7M in grants as PI
- Joseph C. WuDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 8- PendingIpsc-based Vaccine As A Prophylactic And Therapeutic Treatment For CancerUSPTOApplication 17887444
- PendingInduced Pluripotent Stem Cell-based Cancer VaccinesUSPTOApplication 17827957
- PendingInduced Pluripotent Stem Cell-based Cancer VaccinesUSPTOApplication PCTUS2022031491
Show all 8 patent records
- Ipsc-based Vaccine As A Prophylactic And Therapeutic Treatment For CancerJun 15, 2023 · Application 17887444Pending
- Induced Pluripotent Stem Cell-based Cancer VaccinesDec 8, 2022 · Application 17827957Pending
- Induced Pluripotent Stem Cell-based Cancer VaccinesApplication PCTUS2022031491Pending
- Induced Pluripotent Stem Cell-based Cancer VaccinesApplication 63233141Pending
- Ipsc-based Vaccine As A Prophylactic And Therapeutic Treatment For CancerApplication 63233132Pending
- Induced Pluripotent Stem Cell-based Cancer VaccinesApplication 63195609Pending
- Ipsc-based Vaccine As A Prophylactic And Therapeutic Treatment For CancerApplication 62612826Pending
- Ipsc-based Vaccine As A Prophylactic And Therapeutic Treatment For CancerApplication PCTUS2022040273Pending
Related companies, and why
- ZEBRA BIOLOGICS INCSimilar federal contract value in Biotech · null in contracts
- ONCOTRAP INCSimilar federal contract value in Biotech · null in contracts
- XYLOCOR THERAPEUTICS INCSimilar federal contract value in Biotech · null in contracts
- Phenovista Biosciences LLCSimilar federal contract value in Biotech · null in contracts
- NAVEGA THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- ANTIDOTE THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .